PWRD yields 0.17% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, PWRD + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PWRD + MRK for your $10,000?
PWRD is a concentrated stock portfolio of companies perceived to drive and benefit from the energy transition to net zero carbon emissions. Using a proprietary framework, the fund screens the broad US equity market to select companies with a strategy to reduce or enable decarbonization at scale. Selection combines a top-down analysis of the economy with a bottom-up, industry-by-industry, and company-by-company assessment. The adviser does not use sustainability ratings or rankings to exclude companies or sectors. As a result, the portfolio may focus on the most carbon-intensive industries in order for the adviser to drive change through its proxy voting guidelines. Such guidelines encourage companies to invest in their employees, communities, customers, and the environment. The adviser has discretion to target specific investment opportunities. Prior to October 13, 2023, the fund was called the Engine No. 1 Transform Climate ETF. Prior to Feb. 3, 2025, the fund had a ticker of NETZ.
Full PWRD Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.